Reproducibility of current classifications of endometrial endometrioid glandular proliferations: Further evidence supporting a simplified classification

Histopathology

Volumn 64, Issue 2, 2014, Pages 284-292

  Ordi, Jaume ^a   Bergeron, Christine ^b   Hardisson, David ^c   Mccluggage, W Glenn ^d   Hollema, Harry ^e   Felix, Ana ^f   Soslow, Robert A ^g   Oliva, Esther ^h   Tavassoli, Fattaneh A ⁱ   Alvarado Cabrero, Isabel ^j   Wells, Michael ^k   Nogales, Francisco F ^l  

^a CENTRE FOR RESEARCH IN ENVIRONMENTAL EPIDEMIOLOGY CREAL   (Spain)

^b LABORATOIRE CERBA   (France)

^c HOSPITAL UNIVERSITARIO LA PAZ IDIPAZ   (Spain)

^d ROYAL GROUP OF HOSPITALS   (United Kingdom)

^e UNIVERSITY OF GRONINGEN   (Netherlands)

^f PORTUGUESE ONCOLOGY INSTITUTE   (Portugal)

^g MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^h MASSACHUSETTS GENERAL HOSPITAL   (United States)

ⁱ YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j Hospital Star Medica   (Mexico)

^k UNIVERSITY OF SHEFFIELD   (United Kingdom)

^l UNIVERSITY OF GRANADA   (Spain)

more..

Author keywords

Endometrial carcinoma; Endometrial hyperplasia; Interobserver variability

Indexed keywords

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CURETTAGE; ENDOMETRIAL INTRAEPITHELIAL NEOPLASIA; ENDOMETRIUM BIOPSY; ENDOMETRIUM CARCINOMA; ENDOMETRIUM HYPERPLASIA; EUROPE; FEMALE; HUMAN; HUMAN TISSUE; NORTH AMERICA; PATHOLOGIST; PRIORITY JOURNAL; REPRODUCIBILITY; TUMOR CLASSIFICATION; WORLD HEALTH ORGANIZATION;

ENDOMETRIAL CARCINOMA; ENDOMETRIAL HYPERPLASIA; INTEROBSERVER VARIABILITY;

CARCINOMA IN SITU; ENDOMETRIAL HYPERPLASIA; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; OBSERVER VARIATION; REPRODUCIBILITY OF RESULTS; WORLD HEALTH ORGANIZATION;

EID: 84890158503     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/his.12249     Document Type: Article

References (18)

1. Null DB, Weiland CM, Camlibel AR. Postmenopausal bleeding - first steps in the workup. J. Fam. Pract. 2012; 61; 597-604.
2. Sweet MG, Schmidt-Dalton TA, Weiss PM, Madsen KP. Evaluation and management of abnormal uterine bleeding in premenopausal women. Am. Fam. Physician 2012; 85; 35-43.
3. Kurman RJ, Kaminski PF, Norris HJ. The behavior of endometrial hyperplasia. A long-term study of 'untreated' hyperplasia in 170 patients. Cancer 1985; 56; 403-412.
4. Silverberg SG, Mutter GL, Kurman RJ, Kubik-Huch RA, Nogales FF, Tavassoli FA. Tumours of the uterine corpus. Epithelial tumours and related lesions. In Tavassoli FA, Devilee P eds. World Health Organization classification of tumors. Pathology and genetics. Tumors of the breast and female genital organs. Tumors of the uterine corpus. Lyon: IARC Press, 2003; 221-232.
5. Bergeron C, Nogales FF, Masseroli M et al. A multicentric European study testing the reproducibility of the WHO classification of endometrial hyperplasia with a proposal of a simplified working classification for biopsy and curettage specimens. Am. J. Surg. Pathol. 1999; 23; 1102-1108.
6. Kendall BS, Ronnett BM, Isacson C et al. Reproducibility of the diagnosis of endometrial hyperplasia, atypical hyperplasia, and well-differentiated carcinoma. Am. J. Surg. Pathol. 1998; 22; 1012-1019.
7. Skov BG, Broholm H, Engel U et al. Comparison of the reproducibility of the WHO classifications of 1975 and 1994 of endometrial hyperplasia. Int. J. Gynecol. Pathol. 1997; 16; 33-37.
8. Zaino RJ, Kauderer J, Trimble CL et al. Reproducibility of the diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study. Cancer 2006; 106; 804-811.
9. Mutter GL, Baak JP, Crum CP, Richart RM, Ferenczy A, Faquin WC. Endometrial precancer diagnosis by histopathology, clonal analysis, and computerized morphometry. J. Pathol. 2000; 190; 462-469.
10. Baak JP, Orbo A, van Diest PJ et al. Prospective multicenter evaluation of the morphometric D-score for prediction of the outcome of endometrial hyperplasias. Am. J. Surg. Pathol. 2001; 25; 930-935.
11. Baak JP, Mutter GL. EIN and WHO94. J. Clin. Pathol. 2005; 58; 1-6.
12. Mutter GL. Histopathology of genetically defined endometrial precancers. Int. J. Gynecol. Pathol. 2000; 19; 301-309.
13. Mutter GL, Zaino RJ, Baak JP, Bentley RC, Robboy SJ. Benign endometrial hyperplasia sequence and endometrial intraepithelial neoplasia. Int. J. Gynecol. Pathol. 2007; 26; 103-114.
14. Orbo A, Baak JP, Kleivan I et al. Computerised morphometrical analysis in endometrial hyperplasia for the prediction of cancer development. A long-term retrospective study from northern Norway. J. Clin. Pathol. 2000; 53; 697-703.
15. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977; 33; 159-174.
16. Lee J, Fung KP. Confidence interval of the kappa coefficient by bootstrap resampling. Psychiatry Res. 1993; 49; 97-98.
17. Dietel M. The histological diagnosis of endometrial hyperplasia. Is there a need to simplify? Virchows Arch. 2001; 439; 604-608.
18. Sherman ME, Ronnett BM, Ioffe OB et al. Reproducibility of biopsy diagnoses of endometrial hyperplasia: evidence supporting a simplified classification. Int. J. Gynecol. Pathol. 2008; 27; 318-325.